PHARMACEUTICALS: Date Set For Drugmakers To Hand Over Pricing Data
Government ready to ratchet up its scrutiny of Big Pharma.It's official: A new price reporting era has arrived for drug manufacturers. An interim final rule in the April 6 Federal Register requires all average sales prices for Medicare Part B covered drugs and biologicals to be reported each quarter to the Centers for Medicare & Medicaid Services - starting April 30. Set up by provisions in the reform bill, the ASP reporting requirements include certain oral anti-cancer and immunosuppressive drugs, drugs provided through the durable medical equipment benefit and drugs provided incident to a physician's service...
To read the full article, sign in and subscribe to tci Medicare Compliance & Reimbursement.
Keep pace with evolving Medicare regulations — and onboard your team — with timely analysis of critical updates interpreted in an easy-to-follow, easy-to-apply format. Your subscription to TCI's Medicare Compliance & Reimbursement Alert will equip you to navigate code and guideline changes, CCI edits, and revisions to modifiers, payer policies, the fee schedule, OIG target areas, and more.
Current newsletters added each month
Fully searchable archives - over 4200 articles
ALL years/issues back to 2003 organized by year and issue
Codes mentioned in articles are linked to Code Information pages
Code Information pages link back to related articles
Access to this feature is available in the following products: